Concepedia

Publication | Open Access

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF<i>V600E</i>-Mutant<i>KRAS</i>Wild-Type Metastatic Colorectal Cancer

46

Citations

25

References

2023

Year

Abstract

ClinicalTrials.gov, NCT02278133.

References

YearCitations

Page 1